Israel’s Accelerated Evolution Biotechnologies (AEBi) is developing an anti-cancer technology that identifies multiple peptides (small proteins) for targeting specific cancer cells and any mutations. Each treatment will also include a toxin to suppress the cancer’s ability to deactivate the treatment.
Multiple attack on cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.